Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Diagnosis and therapy of chronic pulmonary hypertension].

Literature DB >> 17468810

[Diagnosis and therapy of chronic pulmonary hypertension].

Horst Olschewski¹, M M Hoeper, M M Borst, R Ewert, E Grünig, F-X Kleber, B Kopp, C Opitz, F Reichenberger, A Schmeisser, D Schranz, I Schulze-Neick, H Wilkens, J Winkler, H Worth.

Abstract

Entities: Disease

Mesh：

Year: 2007 PMID： 17468810 DOI： 10.1007/s00392-007-0508-x

Source DB: PubMed Journal: Clin Res Cardiol ISSN： 1861-0684 Impact factor: 5.460

× No keyword cloud information.

47 in total

1. Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.

Authors: Robyn J Barst; David Langleben; David Badesch; Adaani Frost; E Clinton Lawrence; Shelley Shapiro; Robert Naeije; Nazzareno Galie
Journal: J Am Coll Cardiol Date: 2006-04-24 Impact factor: 24.094

2. Sildenafil citrate therapy for pulmonary arterial hypertension.

Authors: Nazzareno Galiè; Hossein A Ghofrani; Adam Torbicki; Robyn J Barst; Lewis J Rubin; David Badesch; Thomas Fleming; Tamiza Parpia; Gary Burgess; Angelo Branzi; Friedrich Grimminger; Marcin Kurzyna; Gérald Simonneau
Journal: N Engl J Med Date: 2005-11-17 Impact factor: 91.245

3. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension.

Authors: T C Yeo; K S Dujardin; C Tei; D W Mahoney; M D McGoon; J B Seward
Journal: Am J Cardiol Date: 1998-05-01 Impact factor: 2.778

4. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.

Authors: Ronald J Raymond; Alan L Hinderliter; Park W Willis; David Ralph; Edgar J Caldwell; William Williams; Neil A Ettinger; Nicholas S Hill; Warren R Summer; Bennett de Boisblanc; Todd Schwartz; Gary Koch; Linda M Clayton; Maria M Jöbsis; James W Crow; Walker Long
Journal: J Am Coll Cardiol Date: 2002-04-03 Impact factor: 24.094

5. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Authors: R M Califf; K F Adams; W J McKenna; M Gheorghiade; B F Uretsky; S E McNulty; H Darius; K Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; K Swedberg
Journal: Am Heart J Date: 1997-07 Impact factor: 4.749

Review 6. Diagnosis and differential assessment of pulmonary arterial hypertension.

Authors: Robyn J Barst; Michael McGoon; Adam Torbicki; Olivier Sitbon; Michael J Krowka; Horst Olschewski; Sean Gaine
Journal: J Am Coll Cardiol Date: 2004-06-16 Impact factor: 24.094

7. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.

Authors: Michael J Krowka; M Susan Mandell; Michael A E Ramsay; Steve M Kawut; Michael B Fallon; Cosme Manzarbeitia; Manuel Pardo; Paul Marotta; Shinji Uemoto; Markus P Stoffel; Joanne T Benson
Journal: Liver Transpl Date: 2004-02 Impact factor: 5.799

8. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

Authors: Roland Wensel; Christian F Opitz; Stefan D Anker; Jörg Winkler; Gert Höffken; Franz X Kleber; Rakesh Sharma; Manfred Hummel; Roland Hetzer; Ralf Ewert
Journal: Circulation Date: 2002-07-16 Impact factor: 29.690

9. Inhaled iloprost for severe pulmonary hypertension.

Authors: Horst Olschewski; Gerald Simonneau; Nazzareno Galiè; Timothy Higenbottam; Robert Naeije; Lewis J Rubin; Sylvia Nikkho; Rudolf Speich; Marius M Hoeper; Jürgen Behr; Jörg Winkler; Olivier Sitbon; Wladimir Popov; H Ardeschir Ghofrani; Alessandra Manes; David G Kiely; Ralph Ewert; Andreas Meyer; Paul A Corris; Marion Delcroix; Miguel Gomez-Sanchez; Harald Siedentop; Werner Seeger
Journal: N Engl J Med Date: 2002-08-01 Impact factor: 91.245

10. Primary pulmonary hypertension in children may have a different genetic background than in adults.

Authors: Ekkehard Grünig; Rolf Koehler; Gabriel Miltenberger-Miltenyi; Rainer Zimmermann; Matthias Gorenflo; Derliz Mereles; Karlin Arnold; Barbara Naust; Heinrike Wilkens; Andreas Benz; Albrecht von Hippel; Herbert E Ulmer; Wolfgang Kübler; Hugo A Katus; Claus R Bartram; Dietmar Schranz; Bart Janssen
Journal: Pediatr Res Date: 2004-08-04 Impact factor: 3.756

6 in total

1. Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension.

Authors: Henrik ten Freyhaus; Daniel Dumitrescu; Henning Bovenschulte; Erland Erdmann; Stephan Rosenkranz
Journal: Clin Res Cardiol Date: 2009-02-13 Impact factor: 5.460

6. Evaluation of right ventricle pulmonary artery coupling on right ventricular function in post operative tetralogy of Fallot patients underwent for pulmonary valve replacement.

Authors: Bhushan Sandeep; Xin Huang; Yuan Li; Xiaowei Wang; Long Mao; Yue Kan; Dan Xiong; Ke Gao; Xiao Zongwei
Journal: J Cardiothorac Surg Date: 2020-09-10 Impact factor: 1.637